Paula-Ann Francis, MD
Forensic Psychiatry · Weston, FLNPI 1760548028
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $989 and has fallen 80.3% since, to $195 in 2025.
Across 182 payments — averaging $25.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$923
- Neuronetics, Inc.$775
- AbbVie$485
- Lundbeck LLC$463
- Takeda Pharmaceuticals U.S.A., Inc.$324
- Sunovion Pharmaceuticals Inc.$318
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,62299%
- Education$431%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 20 | $923 |
| Neuronetics, Inc. | 24 | $775 |
| AbbVie(2 entities) | 28 | $485 |
| Lundbeck LLC | 23 | $463 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $324 |
| Sunovion Pharmaceuticals Inc. | 16 | $318 |
| Vanda Pharmaceuticals Inc. | 10 | $241 |
| Livanova USA, Inc. | 4 | $201 |
| Neurocrine Biosciences, Inc. | 3 | $200 |
| Adlon Therapeutics L.p. | 7 | $111 |
| Bausch Health US, LLC | 5 | $109 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
| Almatica Pharma LLC | 5 | $82 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Idorsia Pharmaceuticals US Inc | 2 | $43 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $37 |
| Jazz Pharmaceuticals Inc. | 2 | $28 |
| Corium, LLC | 1 | $23 |
| Tris Pharma Inc | 1 | $21 |
| Alkermes, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few forensic psychiatry providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 15 | $39,090 |
| TrintellixVortioxetine Hydrobromide | 13 | $8,855 |
| Duloxetine Hcl | 201 | $5,870 |
| Lurasidone Hcl | 14 | $2,206 |
| Atomoxetine Hcl | 33 | $2,195 |
| Quetiapine Fumarate | 142 | $1,951 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 44 | $1,538 |
| Doxepin Hcl | 42 | $1,278 |
| Buspirone Hcl | 122 | $1,196 |
| Aripiprazole | 34 | $1,191 |
| Clonazepam | 167 | $1,150 |
| Mirtazapine | 60 | $1,034 |
| Trazodone Hcl | 130 | $1,018 |
| Fluoxetine Hcl | 76 | $812 |
| Divalproex Sodium | 80 | $807 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $485 | $39,09015 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $324 | $8,85513 claims |
| Almatica Pharma LLCSertraline Hcl | $82 | $441104 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few forensic psychiatry providers in Floridaon file to place this against a meaningful peer group, so we don't.
Other forensic psychiatry in Weston
- Mary StedmanTampa$19K
- Paul HebigVero Beach$8K
- Cesar RuizKissimmee$327
- Susan MurrayTampa$245
- Cassandra NewkirkBoca Raton$135
- Charles LopiccoloPembroke Pines$50
- Stephen YoungDaytona Beach$36
- Alan WaldmanGainesville$25
- Eduardo InfanteGainesville$20
- Yolanda HernandezGainesville$20
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.